← back to search

Elisée Wiita

Karolinska University Hospital · SE
🔎 Find collaborators in Molecular Biology · Hematology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Molecular Biology · Hematology
Research interest
Research interests include DNA Repair Mechanisms, Biochemical and Molecular Research, Acute Myeloid Leukemia Research, and Folate and B Vitamins Research.
h-index
21
citations
1,995
works
64
NIH funding
primary concept
email

Recent publications

Virtual fragment screening for DNA repair inhibitors in vast chemical space
Nature Communications 2025cited by 13position: middledoi
Formate overflow drives toxic folate trapping in MTHFD1 inhibited cancer cells
Nature Metabolism 2023cited by 50position: middledoi
Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress
Nature Cancer 2022cited by 101position: middledoi
Small-molecule activation of OGG1 increases oxidative DNA damage repair by gaining a new function
Science 2022cited by 74position: middledoi
The First Structure of Human MTHFD2L and Its Implications for the Development of Isoform‐Selective Inhibitors
ChemMedChem 2022cited by 26position: middledoi
Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy
EMBO Molecular Medicine 2020cited by 59position: middledoi
Targeting OGG1 arrests cancer cell proliferation by inducing replication stress
Nucleic Acids Research 2020cited by 58position: middledoi
Novel Broad-Spectrum Antiviral Inhibitors Targeting Host Factors Essential for Replication of Pathogenic RNA Viruses
Viruses 2020cited by 41position: middledoi
Small-molecule inhibitor of OGG1 suppresses proinflammatory gene expression and inflammation
Science 2018cited by 229position: middledoi
Targeting PFKFB3 radiosensitizes cancer cells and suppresses homologous recombination
Nature Communications 2018cited by 129position: middledoi
Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies
Nature Medicine 2017cited by 141position: middledoi
Validation and development of MTH1 inhibitors for treatment of cancer
Annals of Oncology 2016cited by 145position: middledoi
MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool
Nature 2014cited by 529position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Thomas Helleday · Science for Life Laboratory4 papers (2018–2025)Ann‐Sofie Jemth · Science for Life Laboratory2 papers (2020–2022)Evert Homan · Science for Life Laboratory2 papers (2022–2025)Pål Stenmark · Lund University2 papers (2022–2025)Christina Kalderén · Science for Life Laboratory2 papers (2020–2025)Ulrika Warpman Berglund · Orexo (Sweden)2 papers (2020–2025)Emma Rose Scaletti · University of Otago2 papers (2022–2025)Olov Wallner · Karolinska University Hospital2 papers (2020–2025)Armando Cázares‐Körner · Science for Life Laboratory1 papers (2020–2020)Katarina Färnegårdh · Science for Life Laboratory1 papers (2018–2018)Duc Duy Vo · Science for Life Laboratory1 papers (2025–2025)Liuzhen Meng · Science for Life Laboratory1 papers (2025–2025) · 1 papers (2018–2018) · 1 papers (2025–2025) · 1 papers (2018–2018)Åsa Rosenquist · Science for Life Laboratory1 papers (2020–2020)Flavio Ballante · Science for Life Laboratory1 papers (2025–2025)Marjo-Riitta Puumalainen · Science for Life Laboratory1 papers (2020–2020)Yurii S. Moroz · John Wiley & Sons (United States)1 papers (2025–2025) · 1 papers (2018–2018)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Molecular Biology · Hematology →